Talk:Acamprosate

message: Should there be a section on structural/chemical similarities to taurine? I know it might seem unwarranted, but the effects are nearly identical: GabaA activation, neuroprotection (both excitotoxic and ischemic). Although taurine has more widespread effects, I think it should be brought up that they have very similar receptor activation. 69.205.97.220 (talk) 22:02, 9 April 2009 (UTC)
replies: text: says it is calcium acetylhomotaurinate. Is mentioned under Names unsourced. See also Homotaurine. - Rod57 (talk) 14:40, 20 December 2016 (UTC)
thread_title: Structual Similarities

message: Nice to find you here, MessedRocker.
I've made some improvements. Also, I suggest removing the table with the study outcomes. It's generally not a good idea to discuss individual studies in too great detail in encyclopedia articles.--Steven Fruitsmaak (Reply) 15:42, 29 November 2006 (UTC)
replies: text: A bit later, but I would echo the suggestion to remove the study table, for the same reason.  It's too much detail on a single study.  Instead I'd recommend a short prose summary of the findings.  delldot on a public computer talk 02:40, 13 January 2008 (UTC)
thread_title: Comment on GA nomination

message: Looking good - any reason why the references are in the "notes" section, and that there is only one real "reference"? Dr Aaron 10:55, 7 December 2006 (UTC)
replies: text: Good question. Anyways, it was redundant, so I removed it. ★MESSEDROCKER★ 11:50, 7 December 2006 (UTC)
replies: text: I think this article is up there for GA status - I'm going away for a few days, but if it hasn't been reviewed by the time I get back, I'll take another look at it. All the best, Dr Aaron 22:54, 7 December 2006 (UTC)
thread_title: Referencing

message: Hi, I suffer from tinnitus and found out some information about Acamprosate while looking for information on the internet. I know nothing about drugs and haven't a medical or pharmacological(?) background. Can someone with the appropriate knowledge check out the information ? It might be worth mentionning (or maybe not). externallink.  —Preceding unsigned comment added by 91.86.19.193 (talk) 22:02, 18 October 2007 (UTC)
replies: text: There are clinical trials preparing to begin at OHSU--or have all ready begun--under William Martin, PhD.  Cole (talk) 17:04, 11 March 2008 (UTC)
thread_title: Tinnitus

message: Is it better to have a structure image without explict CH2s? What are the Wikipedia rules for drawing structures if any?--ChemSpiderMan (talk) 00:20, 25 January 2008 (UTC)
replies: text: They're at Wikipedia:WikiProject Chemistry/Structure drawing. Fvasconcellos (t·c) 00:27, 25 January 2008 (UTC)
replies: text: I've added a structure without explicit hydrogens and in not the calcium salt form, so that the image matches the data in the box.  -- Ed (Edgar181) 15:55, 25 January 2008 (UTC)
thread_title:  Better to have a structure image without explict CH2s? 

message: This article was nominated for good article reassessment to determine whether or not it met the good article criteria and so can be listed as a good article. The article was delisted. Please see the archived discussion for further information. Geometry guy 23:13, 24 February 2008 (UTC)
thread_title:  [[WP:GAR|Good article reassessment]]  

message: Without anything on contraindications and interactions, very little on side effects, no kinetics, and practically no chemistry, this is far from B class. I'm rating it Start. Sorry I haven't the time for expansion. --ἀνυπόδητος (talk) 20:49, 7 January 2013 (UTC)
thread_title:  Rating Start class

message: I think the wording of this article heavily suggests a use of acamprosate in the treatment of benzodiazepine dependence that is not supported by the current references and the current literature on the topic. My quick Google Scholar and EMBASE search both turn up nothing to support this use outside of comorbid alcohol and benzodiazepine dependence. I would recommend this be better reflected in the article unless there is some good evidence to suggest otherwise. Xeldarith (talk) 01:51, 17 September 2014 (UTC)
thread_title: Use for benzodiazepine dependence - deleted

message: Exploratory Phase 2 Results of Combination Oral Therapy for Alzheimer’s Justify Further Study says "PLEODIAL-I (NCT02361424) was a Phase 2, 12-week preliminary efficacy study of several doses of PXT-864 (a fixed combination of acamprosate and baclofen at low dose) in 45 treatment-naive patients with mild AD". - Rod57 (talk) 14:24, 20 December 2016 (UTC)
thread_title:  Also studied for the treatment of Alzheimer’s disease 

message: Improper format content parked here:
Acamprosate & Nicotine Addiction     https://www.ncbi.nlm.nih.gov/pubmed/21522053
''
I don't have time to work on this article so haven't checked the source but removing content that is not formatted correctly. It may have to removed all together... I'll leave that up to article editors.(Littleolive oil (talk) 02:17, 27 November 2017 (UTC)
thread_title:  Parked content 

message: An editor has identified a potential problem with the redirect :Campral® and has thus listed it for discussion. This discussion will occur at Wikipedia:Redirects for discussion/Log/2022 April 15#Campral® until a consensus is reached, and readers of this page are welcome to contribute to the discussion.  BD2412 T 04:35, 15 April 2022 (UTC)
thread_title:  "Campral®" listed at [[Wikipedia:Redirects for discussion|Redirects for discussion]]